Istradefylline
Who holds supplier records for Istradefylline? 6 organisations hold a current record for Istradefylline: an active US FDA Type II Drug Master File. A further 1 organisation has only historical (inactive) DMF filings. Recorded organisation countries for current records: India (3), Italy (1) and Japan (1); not recorded for 1.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Istradefylline: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/istradefylline
Reading the evidence
- 6 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in India
3 of the 5 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.
- 4 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
- US product patents listed
The latest patent listed in the FDA Orange Book for an approved product containing Istradefylline expires 28 Jan 2028. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.
Current records (6)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Istradefylline. Country is the organisation's recorded country, not necessarily the manufacturing site.
- ALP PHARM BEIJING CO LTDActive DMF 37654 · latest filing Oct 2022
- HOSTER LABS PRIVATE LTDIndia Company GMP cert on recordActive DMF 40030 · latest filing Jul 2024
- MSN LIFE SCIENCES PRIVATE LIMITEDIndia Company GMP cert on recordActive DMF 38721 · latest filing Sept 2023
- PROCOS SPAItaly Company GMP cert on recordActive DMF 38212 · latest filing Apr 2023
- Sun Pharmaceutical Industries LimitedIndia Company GMP cert on recordActive DMF 41747 · latest filing Jun 2025
- TATEYAMA KASEI CO LTDJapanActive DMF 44179 · latest filing Jul 2026
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Historical records (1)
Organisations whose Type II DMFs for Istradefylline are no longer active. These show a past filing, not current supply.
Show all 1 historical record
- Japan · Inactive DMF 23936 · filed Jul 2010
US product patents and exclusivity
The FDA Orange Book lists patents and exclusivities for specific approved products (2 listed products contain Istradefylline). The latest listed patent expires 28 Jan 2028. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.
Overview
Istradefylline is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL431770).
Chemical identity
- IUPAC name
- 8-[(E)-2-(3,4-dimethoxyphenyl)ethenyl]-1,3-diethyl-7-methylpurine-2,6-dione
- Canonical SMILES
- CCN1C2=C(C(=O)N(C1=O)CC)N(C(=N2)/C=C/C3=CC(=C(C=C3)OC)OC)C
- InChIKey
- IQVRBWUUXZMOPW-PKNBQFBNSA-N
- Synonyms
- Istradefilina, Istradefylline, KW-6002, Nourianz, Nouriast, KW 6002, istradefyllinum, RefChem:57357, Istradefylline (KW-6002), KW6002, Istradefylline Impurity 2, Istradefyline
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Istradefylline?
6 organisations hold an active US FDA Type II Drug Master File or a CEP for Istradefylline: ALP PHARM BEIJING CO LTD, HOSTER LABS PRIVATE LTD (India), MSN LIFE SCIENCES PRIVATE LIMITED (India), PROCOS SPA (Italy), Sun Pharmaceutical Industries Limited (India) and TATEYAMA KASEI CO LTD (Japan). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Istradefylline Drug Master Files are active?
ALP PHARM BEIJING CO LTD (DMF 37654), HOSTER LABS PRIVATE LTD (DMF 40030), MSN LIFE SCIENCES PRIVATE LIMITED (DMF 38721), PROCOS SPA (DMF 38212), Sun Pharmaceutical Industries Limited (DMF 41747) and TATEYAMA KASEI CO LTD (DMF 44179). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Istradefylline records mean?
1 organisation has only inactive Type II DMFs for Istradefylline. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does the FDA Orange Book list patents for products containing Istradefylline?
Yes. The latest patent listed for an approved US product containing Istradefylline expires 28 Jan 2028, across 2 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.
How do I qualify a Istradefylline supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Istradefylline?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.